covid
Buscar en
Angiología
Toda la web
Inicio Angiología Tumores del glomus carotídeo: estudio de 11 años
Journal Information
Vol. 58. Issue 2.
Pages 91-97 (January 2006)
Share
Share
Download PDF
More article options
Vol. 58. Issue 2.
Pages 91-97 (January 2006)
Full text access
Tumores del glomus carotídeo: estudio de 11 años
Carotid glomus tumours: an 11-year study
Visits
6433
M.J. González-Fueyo
Corresponding author
mjgfueyo_1@hotmail.com

Correspondencia: Servicio de Angiología, Cirugía Vascular y Endovascular. Hospital de León. Altos de Nava, s/n. E-24071 León.
, M. Ballesteros-Pomar, J. Domínguez-Bahamonde, J. Zarco-Castillo, R. Fernández-Samos
Servicio de Angiología, Cirugía Vascular y Endovascular. Complejo Hospitalario de León. León, España
This item has received
Article information
Resumen
Introducción

Los tumores del glomus carotídeo son lesiones de crecimiento lento, hipervascularizados, infrecuentes, derivados de células paraganglionares de la cresta neural y que representan casi la mitad de todos los paragangliomas.

Objetivo

Estudio retrospectivo de los tumores del glomus carotídeo tratados en nuestro servicio en los últimos 11 años.

Pacientes y métodos

Siete casos en seis pacientes (uno bilateral). Edad media: 68 años (59-93 años). Dos hombres y cuatro mujeres. La forma de presentación más común fue una masa cervical pulsátil. Ningún paciente refería antecedentes familiares de paragangliomas. Se descartó enfermedad diseminada en todos los casos. Diagnóstico mediante angio-TAC (tomografía axial computarizada) y angiografía en todos los casos. Seis casos intervenidos (uno bilateral), mediante abordaje cervical y extirpación completa (resección subadventicial). En los tres últimos casos se practicó embolización preoperatoria. Ningún caso requirió reconstrucción vascular. Un caso no se intervino debido a la edad avanzada de la paciente.

Resultados

Según los criterios de clasificación de Shamblin, un caso era de tipo III, tres de tipo II y dos de tipo I. Tamaño medio: 2,8cm (1-4cm). Ningún caso presentó criterios de malignidad. Las determinaciones de catecolaminas fueron normales. No hubo eventos cerebrovasculares intraoperatorios ni postoperatorios. Complicaciones menores: una disfonía leve y un granuloma con una fístula cutánea resuelta. En el seguimiento, dos pacientes han fallecido por causas independientes al paraganglioma; el resto permanece asintomático.

Conclusiones

A pesar de la baja incidencia de los paragangliomas carotídeos, es una patología de indicación quirúrgica, que debe ser tratada por cirujanos vasculares, a fin de proporcionar altas tasas de curación y baja morbimortalidad.

Palabras clave:
Carótida
Embolización
Glomus
Paraganglioma
Tumor del glomus
Summary
Introduction

Carotid glomus tumours are rare, slow-growing, hypervascularised lesions that derive from the paraganglionic cells of the neural crest and account for almost half of all paragangliomas.

Aim

We conducted a retrospective study of the carotid glomus tumours treated in our service over the past 11 years.

Patients and methods

The study involved seven cases in six patients (one was bilateral). Mean age: 68 years (59-93 years). Two males and four females. The most common form of presentation was a pulsatile mass in the neck. None of the patients had a history of paragangliomas in the family. Disseminated disease was precluded in all cases. All cases were diagnosed using angiography-CAT (computerised axial tomography) and angiography. Surgery was performed in six cases (one bilateral) and involved a cervical approach and complete removal (subadventitial resection). Pre-operative embolisation was carried out in the last three cases. None of the cases required vascular reconstruction. One case was not submitted to surgery due to the advanced age of the patient.

Results

According to the Shamblin classification criteria, one case was type III, three were type II and two were type I. Mean size: 2.8cm (1-4cm). None of the cases met malignancy criteria. Tests for catecholamines were normal. There were no intraoperative or post-operative cerebrovascular events. Minor complications: a mild dysphonia and a granuloma with resolved cutaneous fistula. In the follow-up two patients died due to causes that were not related to the paraganglioma; the others remained asymptomatic.

Conclusions

Despite the low incidence of carotid paragangliomas, it is a pathology that requires surgery and must be treated by vascular surgeons in order to ensure high cure rates and low morbidity and mortality rates.

Key words:
Carotid artery
Embolisation
Glomus
Glomus tumour
Paraganglioma
Full text is only aviable in PDF
Bibliografía
[1.]
Luna-Ortiz K., Rascón-Ortiz M., Villavicencio-Valencia V., Granados-García M., Herrera-Gómez A..
Carotid body tumors: review of a 20-year experience.
[2.]
Díez-Porres L., García-Iglesias F., Pérez-Martín G., García Puig J., Gil Aguado A..
Paraganglioma multicéntrico: cuidado con la cirugía.
Rev Clin Esp, 203 (2003), pp. 434-438
[3.]
Ysa-Figueras A.Y., Miralles M., Bosch J.M., Munné A., Pijuan L., Vidal-Barraquer F..
Quemodectoma asociado a paraganglioma del vago: resección mediante subluxación mandibular.
Angiología, 54 (2002), pp. 38-43
[4.]
Rodríguez-Cuevas H., Lau I., Rodríguez H.P..
High-altitude paragangliomas: diagnostic and therapeutic considerations.
Cancer, 57 (1986), pp. 672-676
[5.]
Davidovic L.B., Djukic V.B., Vasic D.M., Sindjelic R.P., Duvnjak S.N..
Diagnosis and treatment of carotid body paraganglioma: 21 years of experience at clinical center of Serbia.
World J Surg Oncol, 3 (2005), pp. 10
[6.]
Miselli A., Bresciani P., Soana G., Bianchi E., Cocchi S., Marchini L..
Carotid glomus tumors.
Study of two cases using color Duplex ultrasonography. Radiol Med (Torino), 88 (1994), pp. 877-880
[7.]
Kwekkeboom D.J., van Urk H., Pauw B.k., Lamberts S.W., Kooij P.P., Hoogma R.P., et al.
Osteroid scintigraphy for detection of paragangliomas.
J Nucl Med, 34 (1993), pp. 873-878
[8.]
Iafrati M.D., O'Donnell T.F. Jr.
Adjuvant techniques for the management of large carotid body tumors.
A case report and review. Cardiovasc Surg, 7 (1999), pp. 139-145
[9.]
Murat E. Surgical techniques for carotid body tumors. URL: http://www.wjso.com/content/3/1/10/comments#175454. Fecha última consulta: 06.03.2005.
[10.]
Roistacher S.L..
Carotid body tumor with concurrent masticatory pain dysfunction.
Oral Surg Oral Med Oral Pathol, 83 (1997), pp. 10-13
[11.]
Grufferman M., Gillman R., Pasternak C., Peterson C.L., Young W.G. Jr.
Familial carotid body tumors: case report and epidemiologic review.
Cancer, 46 (1980), pp. 2116-2122
[12.]
Mall J., Saclarides T., Doolas A., Eibl-Eibestfeld B..
first report of hepatic lobotomy for metastatic carotid body tumor.
J Cardiovasc Surg, 41 (2000), pp. 759-761
[13.]
Leonetti J., Donzelli J., Littooy F., Farrel B..
Perioperative strategies in the management of carotid body tumors.
Otolaryngol Head Neck Surg, 117 (1997), pp. 111-115
[14.]
Granell M., Tommasi M., Úbeda J., Chaves S., Soriano J.L., Todolï J., et al.
Implicaciones anestesiológicas de la exéresis de paragangliomas carotídeos.
A propósito de tres casos clínicos. Rev Esp Anestesiol Reanim, 48 (2001), pp. 387-392
[15.]
Ridge B.A., Brewster D.C., Darling R.C., Cambria R.P., Lamuraglia G.M., Abbott W.M..
Familial carotid body tumors: incidence and implications.
Ann Vasc Surg, 7 (1993), pp. 190-194
[16.]
Sobol S.M., Dailey J.C..
Familial multiple cervical paragangliomas: report of a kindred and review of the literature.
Otolaryngol Head Neck Surg, 102 (1990), pp. 382-390
[17.]
Gil Franca L.H., Gomes Bredt C., Vedolin A., Back L.A., Stahlke H.J. Jr.
Surgical treatment of the carotid body tumor: a 30 year experience.
Jornal Vascular Brasileiro, 2 (2003), pp. 171-175
[18.]
Rinaldo A., Ferlito A., Myssiorek D., Devaney K.O..
Which paragangliomas of the head and neck have a higher rate of malignancy?.
[19.]
Walsh R.M., Leen E.J., Gleeson M.J., Shaheen O.H..
Malignant vagal paraganglioma.
J Laryngol Otol, 111 (1997), pp. 83-88
[20.]
Meyer F.B., Sundt T.M. Jr, Pearson B.W..
Carotid body tumors: a subject review and suggested surgical approach.
J Neurosurg, 64 (1986), pp. 377-385
[21.]
Shamblin W.R., ReMine W.H., Sheps S.G., Harrison E.G. Jr.
Carotid body tumor (chemodectoma): clinicopathologic analysis of ninety cases.
Am J Surg, 122 (1971), pp. 732-739
[22.]
Laube H.R., Fahrenkamp A.G., Backer W., Scheld H.H..
Glomus tumors: a diagnostic and surgical challenge?.
J Cardiol, 83 (1994), pp. 373-380
[23.]
Mayer R., Fruhwirth J., Beham A., Groell R., Poschauko J., Hackl A..
Radiotherapy as adjunct to surgery for malignant carotid body paragangliomas presenting with lymph node metastases.
Strahlenther Onkol, 176 (2000), pp. 356-360
[24.]
Litle V.R., Reilly L.M., Ramos T.K..
Preoperative embolization of carotid body tumors: when is it appropriate?.
An Vasc Surg, 10 (1996), pp. 464-468
[25.]
Matticari S., Credi G., Pratesi C., Bertini D..
Diagnosis and surgical treatment of the carotid body tumors.
J Cardiovasc Surg, 36 (1955), pp. 233-239
[26.]
Tripp H.F. Jr, Fail P.S., Beyer M.G., Chaisson G.A..
New approach to preoperative vascular exclusion for carotid body tumor.
J Vasc Surg, 38 (2003), pp. 389-391
[27.]
Muhm M., Polterauer P., Gstottner W., Temmel A., Richling B., Undt G., et al.
Diagnostic and therapeutic approaches to carotid body tumors.
Review of 24 patients. Arch Surg, 132 (1997), pp. 279-284
[28.]
Rabl H., Friehs I., Gutschi S., Pascher O., Koch G..
Diagnosis and treatment of carotid body tumors.
Thorac Cardiovasc Surg, 41 (1993), pp. 340-343
[29.]
Hallett J.W., Nora J.D., Hollier L.H., Cherry K.J. Jr, Pairolero P.C..
Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas: a fifty-year experience with 153 tumors.
J Vasc Surg, 7 (1988), pp. 284-291
[30.]
Mitchell R.O., Richardson J.D., Lambert G..
Characteristics, surgical management, and outcome in 17 carotid body tumors.
Am Surg, 62 (1996), pp. 1034-1037
Copyright © 2006. SEACV
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos